TALTZ 20 mg/.25mL
ixekizumab · INJECTION, SOLUTION · Eli Lilly and Company
Taltz (ixekizumab) is an injectable medication that blocks a protein called interleukin-17A to treat inflammatory conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is given as a subcutaneous injection and works by reducing the immune system's inflammatory response.
Key Facts
- Brand Name
- TALTZ
- Generic Name
- ixekizumab
- NDC Code (Product)
0002-8900- Manufacturer
- Eli Lilly and Company
- Strength
- 20 mg/.25mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125521
- Drug Class
- Interleukin-17A Antagonist [EPC]
- Marketing Start
- 03/22/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is TALTZ used for?
Taltz (ixekizumab) is an injectable medication that blocks a protein called interleukin-17A to treat inflammatory conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is given as a subcutaneous injection and works by reducing the immune system's inflammatory response.
Is TALTZ a controlled substance?
TALTZ is not classified as a controlled substance by the DEA.
What is the generic name for TALTZ?
The generic name for TALTZ is ixekizumab. There are no other listed brand versions of ixekizumab.
What is the NDC code for TALTZ 20 mg/.25mL?
The NDC (National Drug Code) for TALTZ 20 mg/.25mL is 0002-8900, listed by Eli Lilly and Company.
Other TALTZ Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)